- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Exon 53
Total 856 results
-
TakedaCompletedNon-small Cell Lung Cancer (NSCLC)Hong Kong, France, Canada
-
Megan WaldropAudentes TherapeuticsActive, not recruitingDuchenne Muscular DystrophyUnited States
-
PfizerCompletedSystemic Anaplastic Large-Cell Lymphoma | Non-Small Cell Lung Cancer ALK-positive | Non-Small Cell Lung Cancer c-Met Dependent | Non-Small Cell Lung Cancer ROS Marker Positive | Advanced Malignancies Except LeukemiaUnited States, Korea, Republic of, Australia, Japan
-
Dizal PharmaceuticalsActive, not recruitingNon-Small Cell Lung CancerChina
-
ProQR TherapeuticsTerminatedEye Diseases | Retinitis Pigmentosa | Eye Diseases, Hereditary | Vision Disorders | Retinal Disease | Eye Disorders Congenital | Usher Syndrome Type 2 | Deaf BlindUnited States, United Kingdom
-
Exonate LimitedNovotech (Australia) Pty LimitedCompleted
-
Novartis PharmaceuticalsCompletedMetastatic Non-Small Cell Lung CancerUnited States
-
ProQR TherapeuticsTerminatedRetinitis Pigmentosa | Usher Syndrome Type 2United States, Canada, France
-
Alpha Biopharma (Jiangsu) Co., Ltd.CompletedNon-small Cell Lung Cancer | Brain Metastases | EGFR Gene MutationChina, Korea, Republic of, Singapore, Taiwan
-
Black Diamond Therapeutics, Inc.TerminatedSolid TumorUnited States, Denmark, France, Spain
-
Royal Marsden NHS Foundation TrustMerck KGaA, Darmstadt, Germany; University of Oxford; University of SurreyTerminatedMicrosatellite Instability | Stage III Colon Cancer | POLE Exonuclease Mutant Colon CancerUnited Kingdom
-
Millennium Pharmaceuticals, Inc.Approved for marketing
-
ProQR TherapeuticsActive, not recruitingEye Diseases | Retinitis Pigmentosa | Eye Diseases, Hereditary | Vision Disorders | Retinal Disease | Eye Disorders Congenital | Usher Syndrome Type 2 | Deaf BlindUnited States, Netherlands, United Kingdom, Germany
-
ETOP IBCSG Partners FoundationCompleted
-
National Taiwan University HospitalCompletedTumor Progression | EGFR Exon 19 MutationTaiwan
-
Sarepta Therapeutics, Inc.CompletedMuscular Dystrophy, DuchenneUnited States, Canada
-
ProQR TherapeuticsCompletedEye Diseases | Retinitis Pigmentosa | Eye Diseases, Hereditary | Vision Disorders | Retinal Disease | Eye Disorders Congenital | Usher Syndrome Type 2 | Deaf BlindUnited States, Canada, France
-
Centre Hospitalier Régional d'OrléansCompleted
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...Completed
-
Massachusetts General HospitalNovartisCompletedMalignant Non-small Cell Neoplasm of Lung Stage IVUnited States
-
Targovax ASATerminated
-
Sarepta Therapeutics, Inc.CompletedDuchenne Muscular DystrophyBelgium, France, Italy, United Kingdom
-
Allist Pharmaceuticals, Inc.Withdrawn
-
Seoul National University HospitalAstraZeneca; Korean Cancer Study GroupCompletedLocally Advanced or Metastatic NSCLCKorea, Republic of
-
Phoenicis TherapeuticsTerminatedEpidermolysis Bullosa Dystrophica, Recessive | Epidermolysis Bullosa Dystrophica, DominantUnited States, Spain, France
-
Sarepta Therapeutics, Inc.CompletedDuchenne Muscular DystrophyUnited States
-
Centre Hospitalier Régional de la CitadelleRoche Pharma AG; Biogen; AveXis, Inc.; Association Belge contre les Maladies neuro...CompletedSpinal Muscular AtrophyBelgium
-
Sarepta Therapeutics, Inc.CompletedDuchenne Muscular Dystrophy (DMD)United States
-
Sarepta Therapeutics, Inc.Completed
-
Novartis PharmaceuticalsWithdrawnNon-small Cell Lung Carcinoma (NSCLC)
-
Hanmi Pharmaceutical Company LimitedTerminatedNSCLCKorea, Republic of, China
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)CompletedLung Non-Squamous Non-Small Cell Carcinoma | Stage IV Lung Non-Small Cell Cancer AJCC v7 | EGFR Exon 19 Deletion Mutation | EGFR NP_005219.2:p.L858RUnited States
-
Ospedale Maggiore Di TriesteUnknownHodgkin Lymphoma | Radiotherapy | Immune Checkpoint InhibitorItaly
-
Les Laboratoires des Médicaments StérilesCompletedPlacental Insufficiency | EnoxaparinTunisia
-
Sarepta Therapeutics, Inc.CompletedMuscular Dystrophy, DuchenneUnited States
-
Sarepta Therapeutics, Inc.CompletedDuchenne Muscular Dystrophy (DMD)United States
-
Tianjin Medical University Cancer Institute and...UnknownNon Small Cell Lung CancerChina
-
University of Illinois at Urbana-ChampaignCompleted
-
Chang Gung Memorial HospitalCompletedGastrointestinal Stromal Tumour (GIST)Taiwan
-
Asan Medical CenterUnknownCancer | Lung Cancer Metastatic | MET Gene MutationKorea, Republic of
-
Institut de Cancérologie de LorraineCompletedFibrosis | Breast CarcinomaFrance
-
Novartis PharmaceuticalsWithdrawnCarcinoma | Non-Small-Cell Lung Cancer
-
Cooperative International Neuromuscular Research...UnknownBecker Muscular DystrophyUnited States, Canada, Italy, United Kingdom
-
Massachusetts General HospitalCompletedNon Small Cell Lung CancerUnited States
-
BioMarin PharmaceuticalNo longer availableDuchenne Muscular DystrophyUnited States, Germany, United Kingdom, Japan, Netherlands, France, Spain, Korea, Republic of, Italy, Belgium, Taiwan, Argentina, Australia, Bulgaria, Czechia, Israel, Norway, Poland, Russian Federation, Turkey
-
EPS CorporationCompletedLiver Only Metastasis From KRAS Exon 2 Wild Type (Under Protocol 1.0-1.2 Edition) and RAS Wild Type (Under Protocol 2.0 Edition) Colorectal CancerJapan
-
EPS CorporationCompleted
-
Betta Pharmaceuticals Co., Ltd.Unknown
-
Sebastian BauerHannover Medical School; University Hospital Tuebingen; Universitätsmedizin Mannheim and other collaboratorsUnknownGIST, Malignant | KIT Gene Mutation | KIT Exon 13 MutationGermany